Fraud in Clincal Research May 2010

Course Description

Fraudulent activities in clinical research undermine clinical research professionals’ ability to meet their obligations for ensuring credible data is obtained from protected participants. This course provides an overview of fraud in clinical research and its potential impact on the industry and the public’s health.


Learning Objectives

  • Discuss significant and current examples of fraud in clinical research
  • Describe the current focus of regulatory and Congressional bodies
  • Explain the Sponsor/CRO, IRB, Clinical Investigator, and Study Staff role in detection and prevention
  • Recognize the impact and consequences of fraud in clinical research
  • Landmark and recent cases of fraud in clinical research
  • Regulatory authorities’ current focus and findings
  • Group discussions of best practices 

Who Should Attend

  • Clinical Quality Assurance Professionals
  • Clinical Research Associates
  • Project Managers
  • Clinical Investigators
  • Study Coordinators
  • IRB Professionals
  • Institutional Officials involved in oversight of clinical research
  • Data Management Professionals
  • Regulatory Affairs Professionals

Elizabeth Ronk Nelson, MPH

Click here for complete trainer biographies  

Course Length Time

2 hours 1:00 - 3:00 p.m. Eastern

Course Dates

May 12, 2010

Hold this course at your company!

For more information, contact Naila Ganatra at (215) 413-2471